GE HealthCare expects 8–12% EPS growth and $1.7B free cash flow in 2026 as new products ramp

GEHC Q4 2025 earnings call recap: revenue, record backlog, 2026 guidance, Intelerad deal, Flyrcado ramp, tariffs & China risks—read key takeaways.

Fabrinet falls despite Q2, outlook beat, while analysts remain bullish

Shares of Fabrinet (FN) fell on Tuesday despite Q2 results and outlook exceeding estimates, which saw largely positive reactions from analysts.